Mauro Biffi, Eduardo Celentano, Massimo Giammaria, Antonio Curnis, Giovanni Rovaris, Matteo Ziacchi, Gennaro Miracapillo, Davide Saporito, Matteo Baroni, Fabio Quartieri, Massimiliano Marini, Patrizia Pepi, Gaetano Senatore, Fabrizio Caravati, Valeria Calvi, Luca Tomasi, Gerardo Nigro, Luca Bontempi, Francesca Notarangelo, Vincenzo Ezio Santobuono, Giulio Boggian, Giuseppe Arena, Francesco Solimene, Marzia Giaccardi, Giampiero Maglia, Alessandro Paoletti Perini, Mario Volpicelli, Daniele Giacopelli, Alessio Gargaro, Saverio Iacopino
BACKGROUND: Atrial high-rate episodes (AHRE) are frequent in patients with cardiac implantable electronic devices. A decrease in device-detected P-wave amplitude may be an indicator of periods of increased risk of AHRE. OBJECTIVE: To assess the association between P-wave amplitude and AHRE incidence. METHODS: Remote monitoring data from 2,579 patients with no history of atrial fibrillation (23% pacemakers, 77% implantable cardioverter-defibrillators [ICDs] of which 40% providing cardiac resynchronization therapy [CRT]) were used to calculate the mean P-wave amplitude during 1 month after implantation...
March 15, 2024: Heart Rhythm: the Official Journal of the Heart Rhythm Society